Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention

Published:2020-12-02 Issue:2 Volume:44 Page:176-185
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Huang Zhuoshan¹,Shui Xing¹,Ling Yesheng¹,Zhou Linli²,Shi Wenqi³,Luo Yanting¹,Li Suhua¹,Zhu Jieming¹,Yu Shujie¹,Liu Jinlai¹^ORCID

Affiliation:

1. Department of Cardiovascular Medicine The Third Affiliated Hospital, Sun Yat‐sen University Guangzhou China

2. Mental and Neurological Diseases Research Center Office The Third Affiliated Hospital, Sun Yat‐sen University Guangzhou China

3. Medical Records Management Office The Third Affiliated Hospital, Sun Yat‐sen University Guangzhou China

Funder

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23520

Reference51 articles.

1. A Test in Context: Lipoprotein(a)

2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

3. Structure of low density lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL

4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

5. Lipid‐related markers and cardiovascular disease prediction;Emerging Risk Factors Collaboration;Jama,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived;Journal of Clinical Lipidology;2023-09

2. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial;BMJ Open;2023-07

3. Are we seeing the light at the end of the tunnel for high lipoprotein(a)? Lipoprotein(a);European Atherosclerosis Journal;2023-04-20

4. New opportunities for identifying the risk of cardiovascular events in young people: the role of familial hypercholesterolemia;Russian Journal of Cardiology;2023-01-05

5. Relationship Between Preprocedural Lipid Levels and Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention;Texas Heart Institute Journal;2022-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3